1. Myeloid Cell Hypoxia-Inducible Factors Promote Resolution of Inflammation in Experimental Colitis
   Nan Lin et al, 2018, Front. Immunol. CrossRef
2. The Role of the Aryl Hydrocarbon Receptor (AHR) in Immune and Inflammatory Diseases.
   Drew R Neavin et al, 2018, Int J Mol Sci CrossRef
3. Impact of CH223191-Induced Mitochondrial Dysfunction on Its Aryl Hydrocarbon Receptor Agonistic and Antagonistic Activities
   Afshin Mohammadi-Bardbori et al, 2019, Chem. Res. Toxicol. CrossRef
4. Tryptophan Metabolites Along the Microbiota-Gut-Brain Axis: An Interkingdom Communication System Influencing the Gut in Health and Disease
   Annalisa Bosi et al, 2020, Int J�Tryptophan�Res CrossRef
5. Nutritional Therapy to Modulate Tryptophan Metabolism and Aryl Hydrocarbon-Receptor Signaling Activation in Human Diseases
   Mohammed Ghiboub et al, 2020, Nutrients CrossRef
6. Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation
   Jing-Ru Liu et al, 2020, Cell. Mol. Life Sci. CrossRef
7. Impact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease
   Davide Banfi et al, 2021, IJMS CrossRef
8. Indol-3-Carbinol and Quercetin Ameliorate Chronic DSS-Induced Colitis in C57BL/6 Mice by AhR-Mediated Anti-Inflammatory Mechanisms
   Sina Riemschneider et al, 2021, IJERPH CrossRef
9. Potential Modulatory Microbiome Therapies for Prevention or Treatment of Inflammatory Bowel Diseases
   Daan V. Bunt et al, 2021, Pharmaceuticals CrossRef
10. Amino Acid Trp: The Far Out Impacts of Host and Commensal Tryptophan Metabolism
    Heather M. Grifka-Walk et al, 2021, Front. Immunol. CrossRef
11. Tissue-Resident T Cells in Chronic Relapsing–Remitting Intestinal Disorders
    Juliana Barreto de Albuquerque et al, 2021, Cells CrossRef
12. Intestinal Flora-Derived Kynurenic Acid Protects Against Intestinal Damage Caused by Candida albicans Infection via Activation of Aryl Hydrocarbon Receptor
    Zetian Wang et al, 2022, Front. Microbiol. CrossRef
13. Evaluating macro- and micronutrients and food groups intake with the risk of developing inflammatory bowel disease: Is there any association?
    Farnaz Farsi et al, 2022, Food Sci Nutr CrossRef
14. 6-Formylindolo(3,2-b)carbazole Dampens Inflammation and Reduces Endotoxin-Induced Kidney Injury via Nrf2 Activation
    Hevna Dhulkifle et al, 2023, Chem. Res. Toxicol. CrossRef
15. Modulating AHR function offers exciting therapeutic potential in gut immunity and inflammation
    Yue Chen et al, 2023, Cell Biosci CrossRef
16. Activation of the aryl hydrocarbon receptor in inflammatory bowel disease: insights from gut microbiota
    Jun-Jie Hou et al, 2023, Front. Cell. Infect. Microbiol. CrossRef
17. Profiling of endogenous metabolites and changes in intestinal microbiota distribution after GEN-001 (Lactococcus lactis) administration
    Min-Gul Kim et al, 2024, Korean J Physiol Pharmacol CrossRef
18. Trends in experimental autoimmune prostatitis: insights into pathogenesis, therapeutic strategies, and redefinition
    Robbie SJ Manuel, 2024, Am J Clin Exp Urol CrossRef
19. Indigo naturalis as a potential drug in the treatment of ulcerative colitis: a comprehensive review of current evidence
    Yu Hu et al, 2024, Pharmaceutical Biology CrossRef